These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 16759092
1. Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements. Klinger AL, McComsey DF, Smith-Swintosky V, Shank RP, Maryanoff BE. J Med Chem; 2006 Jun 15; 49(12):3496-500. PubMed ID: 16759092 [Abstract] [Full Text] [Related]
2. Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides. Shank RP, McComsey DF, Smith-Swintosky VL, Maryanoff BE. Chem Biol Drug Des; 2006 Aug 15; 68(2):113-9. PubMed ID: 16999776 [Abstract] [Full Text] [Related]
3. Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform. Maryanoff BE, McComsey DF, Costanzo MJ, Hochman C, Smith-Swintosky V, Shank RP. J Med Chem; 2005 Mar 24; 48(6):1941-7. PubMed ID: 15771438 [Abstract] [Full Text] [Related]
4. Carbonic anhydrase-II inhibition. what are the true enzyme-inhibitory properties of the sulfamide cognate of topiramate? Maryanoff BE, McComsey DF, Lee J, Smith-Swintosky VL, Wang Y, Minor LK, Todd MJ. J Med Chem; 2008 Apr 24; 51(8):2518-21. PubMed ID: 18363349 [Abstract] [Full Text] [Related]
5. Affinity of sulfamates and sulfamides to carbonic anhydrase II isoform: experimental and molecular modeling approaches. Gavernet L, Gonzalez Funes JL, Blanch LB, Estiu G, Maresca A, Supuran CT. J Chem Inf Model; 2010 Jun 28; 50(6):1113-22. PubMed ID: 20481572 [Abstract] [Full Text] [Related]
6. Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors. Akıncıoğlu A, Akbaba Y, Göçer H, Göksu S, Gülçin İ, Supuran CT. Bioorg Med Chem; 2013 Mar 15; 21(6):1379-85. PubMed ID: 23394864 [Abstract] [Full Text] [Related]
7. QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII. Tarko L, Supuran CT. Bioorg Med Chem; 2013 Mar 15; 21(6):1404-9. PubMed ID: 23206986 [Abstract] [Full Text] [Related]
8. Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV. Gavernet L, Gonzalez Funes JL, Palestro PH, Bruno Blanch LE, Estiu GL, Maresca A, Barrios I, Supuran CT. Bioorg Med Chem; 2013 Mar 15; 21(6):1410-8. PubMed ID: 23266178 [Abstract] [Full Text] [Related]
9. Inhibition of carbonic anhydrase II by thioxolone: a mechanistic and structural study. Barrese AA, Genis C, Fisher SZ, Orwenyo JN, Kumara MT, Dutta SK, Phillips E, Kiddle JJ, Tu C, Silverman DN, Govindasamy L, Agbandje-McKenna M, McKenna R, Tripp BC. Biochemistry; 2008 Mar 11; 47(10):3174-84. PubMed ID: 18266323 [Abstract] [Full Text] [Related]
10. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. Minakuchi T, Nishimori I, Vullo D, Scozzafava A, Supuran CT. J Med Chem; 2009 Apr 23; 52(8):2226-32. PubMed ID: 19317447 [Abstract] [Full Text] [Related]
11. Promiscuity of carbonic anhydrase II. Unexpected ester hydrolysis of carbohydrate-based sulfamate inhibitors. Lopez M, Vu H, Wang CK, Wolf MG, Groenhof G, Innocenti A, Supuran CT, Poulsen SA. J Am Chem Soc; 2011 Nov 16; 133(45):18452-62. PubMed ID: 21958118 [Abstract] [Full Text] [Related]
12. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. Innocenti A, Firnges MA, Antel J, Wurl M, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1149-54. PubMed ID: 15686931 [Abstract] [Full Text] [Related]
13. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme. Temperini C, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2010 Jan 15; 20(2):474-8. PubMed ID: 20005709 [Abstract] [Full Text] [Related]
14. QSAR studies on benzene sulfonamide carbonic anhydrase inhibitors: need of hydrophobic parameter for topological modeling of binding constants of sulfonamides to human CA-II. Khadikar PV, Sharma V, Karmarkar S, Supuran CT. Bioorg Med Chem Lett; 2005 Feb 15; 15(4):923-30. PubMed ID: 15686888 [Abstract] [Full Text] [Related]
15. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Casini A, Antel J, Abbate F, Scozzafava A, David S, Waldeck H, Schäfer S, Supuran CT. Bioorg Med Chem Lett; 2003 Mar 10; 13(5):841-5. PubMed ID: 12617904 [Abstract] [Full Text] [Related]
16. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Matulis D, Kranz JK, Salemme FR, Todd MJ. Biochemistry; 2005 Apr 05; 44(13):5258-66. PubMed ID: 15794662 [Abstract] [Full Text] [Related]
17. Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: novel sulfamoylcarbamates and sulfamides derived from acetophenones. Akıncıoğlu A, Akıncıoğlu H, Gülçin İ, Durdagi S, Supuran CT, Göksu S. Bioorg Med Chem; 2015 Jul 01; 23(13):3592-602. PubMed ID: 25921269 [Abstract] [Full Text] [Related]
18. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. J Med Chem; 2005 Dec 01; 48(24):7860-6. PubMed ID: 16302824 [Abstract] [Full Text] [Related]
19. Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates. Isik S, Kockar F, Aydin M, Arslan O, Guler OO, Innocenti A, Scozzafava A, Supuran CT. Bioorg Med Chem; 2009 Feb 01; 17(3):1158-63. PubMed ID: 19124253 [Abstract] [Full Text] [Related]
20. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Temperini C, Cecchi A, Scozzafava A, Supuran CT. Bioorg Med Chem; 2009 Feb 01; 17(3):1214-21. PubMed ID: 19119014 [Abstract] [Full Text] [Related] Page: [Next] [New Search]